Todd Hulgan

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

David W. Haas, Heather J. Ribaudo, Richard B. Kim et al. · PubMed · 2004 · 629 citations

Medicine, Pharmacokinetics, Pharmacology +17

Education of Physicians-in-Training Can Decrease the Risk for Vascular Catheter Infection

Robert J. Sherertz, E. Wesley Ely, Debi M. Westbrook et al. · Annals of Internal Medicine · 2000 · 365 citations

Medicine, Infectious Disease Control, Medical Education +15

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

Kassem Bourgi, Peter F. Rebeiro, Megan Turner et al. · Clinical Infectious Diseases · 2019 · 327 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens

Jamison Norwood, Megan Turner, Carmen Bofill et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 282 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +13

Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study

Todd Hulgan, David W. Haas, Jonathan L. Haines et al. · AIDS · 2005 · 146 citations

Medicine, Molecular Genetics, Neurology +17